New York State Common Retirement Fund Rocket Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,117 shares of RCKT stock, worth $48,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,117
Previous 15,117
-0.0%
Holding current value
$48,676
Previous $101,000
63.37%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding RCKT
# of Institutions
222Shares Held
98.4MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$57 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$26.9 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$19.7 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.5 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $244M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...